NeuroOne Medical Technologies Corp
NMTC0.732USD
+0.009+1.25%
Close 11/05, 16:00（ET）Quotes delayed by 15 min
36.46MMarket Cap
LossP/E TTM
More Details of NeuroOne Medical Technologies Corp Company
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
NeuroOne Medical Technologies Corp Info
Ticker SymbolNMTC
Company nameNeuroOne Medical Technologies Corp
IPO dateNov 09, 2012
CEOMr. David A. (Dave) Rosa
Number of employees17
Security typeOrdinary Share
Fiscal year-endNov 09
Address7599 Anagram Dr
CityEDEN PRAIRIE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code55344-7399
Phone19524261383
Websitehttps://nmtc1.com/
Ticker SymbolNMTC
IPO dateNov 09, 2012
CEOMr. David A. (Dave) Rosa
Company Executives of NeuroOne Medical Technologies Corp
Name
Name/Position
Position
Shareholding
Change
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
615.75K
-0.40%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
230.99K
-11.58%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
136.80K
+25.48%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
114.41K
+32.06%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
101.75K
-0.88%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+43.25%
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
615.75K
-0.40%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
230.99K
-11.58%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
136.80K
+25.48%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
114.41K
+32.06%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
101.75K
-0.88%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+43.25%
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sun, Aug 17
Updated: Sun, Aug 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Merchant Adventure Fund LP
8.40%
Bleichroeder LP
8.00%
Sio Capital Management, LLC
7.05%
Manchester Management Company, L.L.C.
4.73%
Bard Associates Inc.
3.71%
Other
68.12%
Shareholders
Shareholders
Proportion
Merchant Adventure Fund LP
8.40%
Bleichroeder LP
8.00%
Sio Capital Management, LLC
7.05%
Manchester Management Company, L.L.C.
4.73%
Bard Associates Inc.
3.71%
Other
68.12%
Shareholder Types
Shareholders
Proportion
Investment Advisor
17.48%
Hedge Fund
12.99%
Corporation
8.40%
Individual Investor
4.17%
Investment Advisor/Hedge Fund
2.87%
Venture Capital
0.15%
Research Firm
0.14%
Other
53.80%
Institutional Shareholding
Updated: Sun, Oct 5
Updated: Sun, Oct 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
51
16.82M
33.63%
+9.36M
2025Q2
52
13.28M
26.66%
+2.81M
2025Q1
54
11.51M
24.26%
+968.46K
2024Q4
55
12.46M
40.67%
+1.38M
2024Q3
55
11.22M
39.84%
+2.23M
2024Q2
51
10.72M
41.07%
+2.35M
2024Q1
52
11.45M
45.01%
+2.75M
2023Q4
57
9.37M
38.68%
+871.77K
2023Q3
54
7.90M
33.50%
+2.01M
2023Q2
48
4.40M
25.73%
-1.65M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Merchant Adventure Fund LP
4.20M
8.4%
+2.95M
+236.00%
Dec 31, 2024
Bleichroeder LP
4.00M
8%
+4.00M
--
Jun 30, 2025
Sio Capital Management, LLC
3.52M
7.05%
+3.52M
--
Jun 30, 2025
Manchester Management Company, L.L.C.
2.36M
4.73%
+864.05K
+57.60%
Jan 03, 2025
Bard Associates Inc.
1.85M
3.71%
+1.85M
--
Jun 30, 2025
Perkins Capital Management, Inc.
1.50M
3%
+1.50M
--
Jun 30, 2025
The Vanguard Group, Inc.
1.20M
2.41%
+91.91K
+8.27%
Jun 30, 2025
AWM Investment Company, Inc.
916.67K
1.83%
-250.00K
-21.43%
Jun 30, 2025
Rosa (David A)
615.75K
1.23%
-2.46K
-0.40%
Sep 30, 2025
Renaissance Technologies LLC
468.90K
0.94%
+468.90K
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
